Home/Publication/Hostplus et al to Tackle Chronic Inflammatory Diseases
Hostplus et al to Tackle Chronic Inflammatory Diseases 

13 Nov 2025

US$ 20.00

Hostplus and IP Group Australia have co-led the A$29 m (US$19 m) series A round of RAGE Biotech Pty Ltd (Rage Biotech),...

Price / article: US$20.00
OR existing subscriber
Related Publications

Hahn & Co (Hahn) is to dispose of its entire stakes in K Car Co Ltd (K Car) and the latter’s unlisted sister company ......

Glow Capital Partners has acquired a majority stake in Menzies Group Pty Ltd (Menzies) for an undisclosed ......

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.